CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer
暂无分享，去创建一个
A. Schneeweiss | G. Kristiansen | P. Altevogt | P. Lichter | C. Sohn | K. Friedrichs | F. Marmé | B. Burwinkel | A. Ruíz | A. Santoro | A. Benner | P. Sinn | A. Bottini | P. Sánchez‐Rovira | C. Rupp | C. Villena | S. Keller | G. Moldenhauer | V. Khailenko | W. Werft | Xiao-li Wang | N. Bretz | S. Hug | A. Walter | G. Manikhas | M. Biakhov | Anne-kathleen Rupp | M. Seguí | Sascha Keller | Niko P. Bretz | Anne-Kathleen Rupp